[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Agios Pharmaceuticals, Inc. (AGIO) Agios Pharmaceuticals' PYRUKYND receives positive CHMP opinion for adults with thalassemia, but the stock faces downward pressure due to PYRUKYND-related patient deaths and FDA review extensions. ### About Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. (AGIO) is a healthcare company. Agios Pharmaceuticals, Inc. uses the ticker $AGIO for trading. Listed in the [Stocks](/list/stocks) and category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights [#](/topic/$agio/insights) - Agios Pharmaceuticals, Inc. (AGIO) trading volume is up XXXXX% from the previous week. - Agios Pharmaceuticals, Inc. (AGIO) social dominance is up XXXXXX% from the previous week. - Agios Pharmaceuticals, Inc. (AGIO) galaxy score™ is up XXXXXX% from the previous X months. - Agios Pharmaceuticals, Inc. (AGIO) sentiment is up XXX% from the previous month. - Agios Pharmaceuticals, Inc. (AGIO) engagements is up XXXXX% from the previous week. - Agios Pharmaceuticals, Inc. (AGIO) posts created is up XXX% from the previous week. ### Price: $XXXXX [#](/topic/$agio/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$agio/time-series/close.tsv) The price is likely to continue to fall in the short term due to recent deaths related to the drug PYRUKYND, despite positive social sentiment and analyst interest. The recent dips in metrics and market cap declines also suggest a potential downturn. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | XXXX% | XXXX% | XXXXX% | **1-Year High**: $XXXXX on 2024-12-06 **1-Year Low**: $XXXXX on 2025-04-08 ### AltRank: XXX [#](/topic/$agio/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$agio/time-series/alt_rank.tsv) Agios Pharmaceuticals, Inc. (AGIO) is currently AltRank #392 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXX +124 **1 Month**: XXX +99 **6 Months**: XXX -XXX **1 Year**: XXX -XXX **1-Year High**: XXXXX on 2025-08-03 **1-Year Low**: X on 2024-12-29 ### Galaxy Score: XXXXX [#](/topic/$agio/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$agio/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +28 **1 Month**: XX +28 **6 Months**: XX +9 **1 Year**: XX -X **1-Year High**: XX on 2025-06-26 **1-Year Low**: X on 2025-08-28 ### Engagements: XXXXX [#](/topic/$agio/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$agio/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXX **1 Week**: XXXXXX +50% **1 Month**: XXXXXX -XX% **6 Months**: XXXXXXX -XX% **1 Year**: XXXXXXXXX -XX% **1-Year High**: XXXXXX on 2025-09-04 **1-Year Low**: XX on 2025-10-19 | Social Network | X | | -------------- | - | | Engagements | XXXXX | ### Mentions: XX [#](/topic/$agio/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$agio/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XX **1 Month**: XXX -XX% **6 Months**: XXXXX -XX% **1 Year**: XXXXX +6.70% **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-10-19 | Social Network | X | | -------------- | - | | Mentions | XX | ### Creators: XX [#](/topic/$agio/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$agio/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Agios Pharmaceuticals, Inc. (AGIO) in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXXXX +91% **1 Year**: XXXXX +171% **1-Year High**: XXX on 2025-06-28 **1-Year Low**: X on 2025-10-19 The most influential creators that mention Agios Pharmaceuticals, Inc. in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@MarketCap_Live](/creator/twitter/MarketCap_Live) | X | XXX | X | XX | | [@Chat3Free](/creator/twitter/Chat3Free) | X | XXX | XX | XX | | [@OzmosiHealth](/creator/twitter/OzmosiHealth) | X | XXXXX | X | XX | | [@SeanValenc89161](/creator/twitter/SeanValenc89161) | X | XX | X | XX | | [@QuantEmperor](/creator/twitter/QuantEmperor) | X | XXXXX | X | XX | | [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X | XXXXXX | X | XX | | [@SteveDJacobs](/creator/twitter/SteveDJacobs) | X | XXXXX | X | X | [View More](/list/creators/$agio/100) ### Sentiment: XX% [#](/topic/$agio/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$agio/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% +50% **1 Month**: XXX% +67% **6 Months**: XXX% no change **1 Year**: XXX% +3% **1-Year High**: XXX% on 2025-02-22 **1-Year Low**: XX% on 2025-09-08 **Most Supportive Themes** - **Biotech PDUFA Pulse:** (45%) Posts highlighting upcoming FDA decisions and potential catalysts for Agios Pharmaceuticals, Inc. (AGIO). - **Stock Mentions and Trading:** (30%) Posts mentioning AGIO alongside other stocks, often in the context of trading strategies and potential gains. **Most Critical Themes** - **PYRUKYND Related Deaths:** (25%) Mentions of patient deaths associated with the drug PYRUKYND. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXX | XX% | XX | X% | | | | | | | | | | Total | XXX | XX% | XXX | XX% | XX | X% | ### Social Dominance: XXXXXXX% [#](/topic/$agio/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$agio/time-series/social_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXXX% +0.0029% **1 Month**: XXXXXXX% +0.00169% **6 Months**: XXXXXXX% +0.00259% **1 Year**: XXXXXXX% -XXXXX% **1-Year High**: XXXXX% on 2024-10-25 **1-Year Low**: XXXXXX% on 2025-09-30 ### Market Dominance: XXXXXXX% [#](/topic/$agio/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$agio/time-series/market_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: X% **1-Year High**: XXXXXXX% on 2024-11-25 **1-Year Low**: XXXXXXX% on 2025-05-14 ### Market Cap: $XXXXXXXXXXXXX [#](/topic/$agio/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$agio/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXX +$4.20% **1 Month**: $XXXXXXXXXXXXX +$12% **6 Months**: $XXXXXXXXXXXXX +$57% **1-Year High**: $XXXXXXXXXXXXX on 2024-12-06 **1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08 **Top assets mentioned** In the posts about Agios Pharmaceuticals, Inc. in the last XX hours [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Perrigo Company PLC (PRGO)](/topic/$prgo) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [ASE Technology Holding Co., Ltd. (ASX)](/topic/$asx) [A3S Protocol (AA)](/topic/$aa) [Alcoa, Corp. (AA)](/topic/alcoa-corp) [Elanco Animal Health Incorporated Common Stock (ELAN)](/topic/$elan) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [Alkermes Inc. plc (ALKS)](/topic/$alks) **Top topics mentioned** In the posts about Agios Pharmaceuticals, Inc. in the last XX hours [$mbot](/topic/$mbot), [stocks healthcare](/topic/stocks-healthcare), [$ewz](/topic/$ewz), [$psq](/topic/$psq), [stocks technology](/topic/stocks-technology), [coins solana ecosystem](/topic/coins-solana-ecosystem), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [coins real world assets](/topic/coins-real-world-assets), [stocks financial services](/topic/stocks-financial-services), [coins defi](/topic/coins-defi), [$bbio](/topic/$bbio), [investment](/topic/investment), [$prgo](/topic/$prgo), [$ions](/topic/$ions), [$asx](/topic/$asx), [stocks](/topic/stocks), [$aa](/topic/$aa), [alcoa corp](/topic/alcoa-corp), [stocks basic materials](/topic/stocks-basic-materials), [coins arbitrum](/topic/coins-arbitrum), [$elan](/topic/$elan), [$crsp](/topic/$crsp), [$alks](/topic/$alks), [$apge](/topic/$apge), [$bmrn](/topic/$bmrn), [coins dao](/topic/coins-dao), [$bntx](/topic/$bntx), [$cort](/topic/$cort), [$cytk](/topic/$cytk), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [$ceco](/topic/$ceco), [$rcus](/topic/$rcus), [$kros](/topic/$kros), [$sana](/topic/$sana), [$adpt](/topic/$adpt), [$xbi](/topic/$xbi), [$bbc](/topic/$bbc), [$janx](/topic/$janx), [pakistani rupee](/topic/pakistani-rupee), [coins made in usa](/topic/coins-made-in-usa), [$gtx](/topic/$gtx), [$cmc](/topic/$cmc), [coins wallets](/topic/coins-wallets), [$220b](/topic/$220b), [$iron](/topic/$iron), [$owls](/topic/$owls), [$rvmd](/topic/$rvmd), [$ford](/topic/$ford), [$200m2b](/topic/$200m2b), [$prqr](/topic/$prqr), [$abat](/topic/$abat), [$msc](/topic/$msc), [$sli](/topic/$sli), [sanofi](/topic/sanofi), [$insm](/topic/$insm), [biogen inc](/topic/biogen-inc), [$bhvn](/topic/$bhvn), [coins base ecosystem](/topic/coins-base-ecosystem), [bank of america](/topic/bank-of-america), [momentum](/topic/momentum), [signals](/topic/signals), [insider](/topic/insider), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [coins layer 1](/topic/coins-layer-1), [where is](/topic/where-is), [money](/topic/money), [$tern](/topic/$tern), [$tars](/topic/$tars), [$cnta](/topic/$cnta), [$dnli](/topic/$dnli), [$incy](/topic/$incy), [$srrk](/topic/$srrk), [$mrk](/topic/$mrk), [superrare](/topic/superrare), [superrarebears](/topic/superrarebears), [$pfe](/topic/$pfe), [heads](/topic/heads), [cuts](/topic/cuts), [$oncs](/topic/$oncs), [$cvac](/topic/$cvac), [alnylam pharmaceuticals inc](/topic/alnylam-pharmaceuticals-inc), [united states](/topic/united-states), [$llc](/topic/$llc), [$arwr](/topic/$arwr), [oracle](/topic/oracle), [$mtsr](/topic/$mtsr), [$rna](/topic/$rna), [alt aptoslaunch token](/topic/alt-aptoslaunch-token), [$alt](/topic/$alt), [$alec](/topic/$alec), [$advm](/topic/$advm), [$ibb](/topic/$ibb), [$spy](/topic/$spy), [$qqq](/topic/$qqq), [$iwm](/topic/$iwm), [2x](/topic/2x), [$141m](/topic/$141m), [insurance](/topic/insurance), [$bym](/topic/$bym) ### Top Social Posts [#](/topic/$agio/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Bank of America AGIO US: Agios Pharmaceuticals - Positive CHMP opinion bolsters confidence in global approvals - BUY Full report in Telegram (in bio)👆 $AGIO $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE" [X Link](https://x.com/Biobeats99/status/1979607196645384305) [@Biobeats99](/creator/x/Biobeats99) 2025-10-18T17:55Z XXX followers, XXX engagements "$AGIO CHMP backs PYRUKYND for adult thalassemia; EC decision expected early 2026. #pressrelease" [X Link](https://x.com/AponiaAnalytics/status/1979286402673070408) [@AponiaAnalytics](/creator/x/AponiaAnalytics) 2025-10-17T20:40Z 5208 followers, XX engagements "$GME $AMC $BB $OPEN $DNUT $GPRO $KSS $SOFI $PLTR $COIN $MULN $BMGL $HCTI $XELA $AGIO" [X Link](https://x.com/Yan_Chab/status/1979184780559183898) [@Yan_Chab](/creator/x/Yan_Chab) 2025-10-17T13:56Z XX followers, 1964 engagements "$AGIO +5.11% today as Agios' PYRUKYND (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia More Info:" [X Link](https://x.com/OzmosiHealth/status/1979183754150039735) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-10-17T13:52Z 2802 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Agios Pharmaceuticals' PYRUKYND receives positive CHMP opinion for adults with thalassemia, but the stock faces downward pressure due to PYRUKYND-related patient deaths and FDA review extensions.
Agios Pharmaceuticals, Inc. (AGIO) is a healthcare company.
Agios Pharmaceuticals, Inc. uses the ticker $AGIO for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The price is likely to continue to fall in the short term due to recent deaths related to the drug PYRUKYND, despite positive social sentiment and analyst interest. The recent dips in metrics and market cap declines also suggest a potential downturn.
24-Hour | 7-Day | 30-Day |
---|---|---|
XXXX% | XXXX% | XXXXX% |
1-Year High: $XXXXX on 2024-12-06
1-Year Low: $XXXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Agios Pharmaceuticals, Inc. (AGIO) is currently AltRank #392 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +124
1 Month: XXX +99
6 Months: XXX -XXX
1 Year: XXX -XXX
1-Year High: XXXXX on 2025-08-03
1-Year Low: X on 2024-12-29
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +28
1 Month: XX +28
6 Months: XX +9
1 Year: XX -X
1-Year High: XX on 2025-06-26
1-Year Low: X on 2025-08-28
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX +50%
1 Month: XXXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-09-04
1-Year Low: XX on 2025-10-19
Social Network | X |
---|---|
Engagements | XXXXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XXX -XX%
6 Months: XXXXX -XX%
1 Year: XXXXX +6.70%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-19
Social Network | X |
---|---|
Mentions | XX |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Agios Pharmaceuticals, Inc. (AGIO) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +91%
1 Year: XXXXX +171%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-19
The most influential creators that mention Agios Pharmaceuticals, Inc. in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@MarketCap_Live | X | XXX | X | XX |
@Chat3Free | X | XXX | XX | XX |
@OzmosiHealth | X | XXXXX | X | XX |
@SeanValenc89161 | X | XX | X | XX |
@QuantEmperor | X | XXXXX | X | XX |
@BiopharmIQ | X | XXXXXX | X | XX |
@SteveDJacobs | X | XXXXX | X | X |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +50%
1 Month: XXX% +67%
6 Months: XXX% no change
1 Year: XXX% +3%
1-Year High: XXX% on 2025-02-22
1-Year Low: XX% on 2025-09-08
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XXX | XX% | XX | X% |
Total | XXX | XX% | XXX | XX% | XX | X% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% +0.0029%
1 Month: XXXXXXX% +0.00169%
6 Months: XXXXXXX% +0.00259%
1 Year: XXXXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-10-25
1-Year Low: XXXXXX% on 2025-09-30
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2024-11-25
1-Year Low: XXXXXXX% on 2025-05-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$4.20%
1 Month: $XXXXXXXXXXXXX +$12%
6 Months: $XXXXXXXXXXXXX +$57%
1-Year High: $XXXXXXXXXXXXX on 2024-12-06
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Agios Pharmaceuticals, Inc. in the last XX hours
BridgeBio Pharma, Inc. Common Stock (BBIO) Perrigo Company PLC (PRGO) Ionis Pharmaceuticals, Inc. Common Stock (IONS) ASE Technology Holding Co., Ltd. (ASX) A3S Protocol (AA) Alcoa, Corp. (AA) Elanco Animal Health Incorporated Common Stock (ELAN) CRISPR Therapeutics AG (CRSP) Alkermes Inc. plc (ALKS)
Top topics mentioned In the posts about Agios Pharmaceuticals, Inc. in the last XX hours
$mbot, stocks healthcare, $ewz, $psq, stocks technology, coins solana ecosystem, stocks bitcoin treasuries, coins real world assets, stocks financial services, coins defi, $bbio, investment, $prgo, $ions, $asx, stocks, $aa, alcoa corp, stocks basic materials, coins arbitrum, $elan, $crsp, $alks, $apge, $bmrn, coins dao, $bntx, $cort, $cytk, united therapeutics corp, $uthr, $ceco, $rcus, $kros, $sana, $adpt, $xbi, $bbc, $janx, pakistani rupee, coins made in usa, $gtx, $cmc, coins wallets, $220b, $iron, $owls, $rvmd, $ford, $200m2b, $prqr, $abat, $msc, $sli, sanofi, $insm, biogen inc, $bhvn, coins base ecosystem, bank of america, momentum, signals, insider, stocks consumer cyclical, coins layer 1, where is, money, $tern, $tars, $cnta, $dnli, $incy, $srrk, $mrk, superrare, superrarebears, $pfe, heads, cuts, $oncs, $cvac, alnylam pharmaceuticals inc, united states, $llc, $arwr, oracle, $mtsr, $rna, alt aptoslaunch token, $alt, $alec, $advm, $ibb, $spy, $qqq, $iwm, 2x, $141m, insurance, $bym
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Bank of America AGIO US: Agios Pharmaceuticals - Positive CHMP opinion bolsters confidence in global approvals - BUY Full report in Telegram (in bio)👆 $AGIO $BMRN $SRPT $ARWR $ALNY $IONS $BLUE $VRTX $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $DNLI $FATE"
X Link @Biobeats99 2025-10-18T17:55Z XXX followers, XXX engagements
"$AGIO CHMP backs PYRUKYND for adult thalassemia; EC decision expected early 2026. #pressrelease"
X Link @AponiaAnalytics 2025-10-17T20:40Z 5208 followers, XX engagements
"$GME $AMC $BB $OPEN $DNUT $GPRO $KSS $SOFI $PLTR $COIN $MULN $BMGL $HCTI $XELA $AGIO"
X Link @Yan_Chab 2025-10-17T13:56Z XX followers, 1964 engagements
"$AGIO +5.11% today as Agios' PYRUKYND (mitapivat) Receives Positive CHMP Opinion for Adults with Thalassemia More Info:"
X Link @OzmosiHealth 2025-10-17T13:52Z 2802 followers, XXX engagements
/topic/$agio